Multimodal imaging of a patient with RAB39B mutation

Laurane Mackels1, Martin Moïse2, Frédérique Depierreux3,4

  • 1Department of Neurology, CHR Citadelle of Liège, Liège, Belgium.

Neuroradiology
|January 28, 2022
PubMed

Insights

Waisman syndrome, a rare cause of Parkinson Disease (PD), is linked to RAB39B gene mutations. This study presents novel multimodal brain imaging findings in a patient with a new mutation, expanding understanding of this rare neurological condition.

Area of Science:

  • Neurogenetics
  • Neurology
  • Radiology

Background:

  • Waisman syndrome, characterized by intellectual disability and parkinsonism, is a rare condition associated with RAB39B gene mutations.
  • The typical clinical and radiological features of RAB39B-related Parkinson Disease (PD) remain incompletely defined due to its rarity.

Observation:

  • This study details multimodal brain imaging (CT, MRI, US, DaT-SPECT, [18F]FDG-PET) in a 37-year-old male with PD features and mild intellectual disability harboring a novel RAB39B mutation.
  • The patient presented with parkinsonian symptoms and mild mental retardation, alongside specific findings on various imaging modalities.

Findings:

  • The multimodal imaging results partially align with previously reported radiological features of RAB39B mutations.
  • Notably, this case includes the first reported use of [18F]FDG-PET and transcranial ultrasound (US) in a patient with a RAB39B mutation, revealing unique characteristics.
  • The imaging data provides a comprehensive description of the brain in a patient with a new RAB39B mutation.

Implications:

  • This multimodal imaging approach offers valuable insights into the neurobiological underpinnings of Waisman syndrome.
  • The findings contribute to a better understanding of the spectrum of radiological manifestations associated with RAB39B mutations.
  • This case report establishes a precedent for utilizing advanced neuroimaging techniques to characterize rare genetic neurological disorders.